Clinical Trials Directory

Trials / Conditions / Neurotrophic Keratopathy

Neurotrophic Keratopathy

9 registered clinical trials studyying Neurotrophic Keratopathy — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingValidation of Human Drugs Target of Repurposed Drugs and Novel Therapies
NCT06412718
IRCCS Ospedale San Raffaele—
WithdrawnOpen-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Kera
NCT06411145
Dompé Farmaceutici S.p.APhase 4
UnknownEfficacy and Safety of Topical Insulin for Neurotrophic Corneal Ulcers
NCT06331910
Assiut UniversityPhase 4
RecruitingAssessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
NCT05555589
ReGenTree, LLCPhase 3
CompletedPhase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy
NCT04957758
Oyster Point Pharma, Inc.Phase 2
RecruitingAutologous Platelet-rich Plasma (APRP) in the Treatment of Neurotrophic Keratopathy
NCT04604834
Universidad Autonoma de Nuevo LeonN/A
CompletedAn 8-week Follow-up to Evaluate the Renewal of Corneal Nerves Structure and Function in Patients With Neurotro
NCT04293549
G. d'Annunzio University—
TerminatedA Clinical Trial to Asses Efficacy and Safety of Cord Blood Eye Drops in Neurotrophic Keratopathy
NCT03084861
Banc de Sang i TeixitsPhase 1 / Phase 2
TerminatedAssessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEE
NCT02600429
ReGenTree, LLCPhase 3